CSIMarket Company Name, Ticker, Competitors, else..
 
Maze Therapeutics Inc   (NASDAQ: MAZE)
 
Price: $26.0500 $-0.16 -0.610%
Day's High: $27.790000915527344 Week Perf: 16.35 %
Day's Low: $ 25.42 30 Day Perf: -11.93 %
Volume (M): 925,457 52 Wk High: $ 53.65
Volume (M$): $ 0 52 Wk Avg: $33.05
Open: $26.23 52 Wk Low: $21.95



 Market Capitalization (Millions $) 1,537
 Shares Outstanding (Millions) 59
 Employees 141
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -134
 Cash Flow (TTM) (Millions $) -66
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company is a clinical-stage biopharmaceutical firm that develops therapeutic candidates. It utilizes its Compass platform to identify new therapeutic targets and advance them into clinical development, with the goal of obtaining and maintaining regulatory approval for its therapies.


   Company Address: 171 Oyster Point Blvd. South San Francisco 94080 CA
   Company Phone Number: 850-5070   Stock Exchange / Ticker: NASDAQ MAZE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Exploring the Therapeutic Promise of MZE782 First-in-Human Phase 1 Results of a Novel SLC6A19 Inhibitor for Phenylk...

Published Thu, Sep 11 2025 12:22 PM UTC

Maze Therapeutics has recently announced promising first-in-human results from a Phase 1 clinical trial of MZE782, a novel oral SLC6A19 inhibitor. This groundbreaking research shows potential implications for the treatment of both Phenylketonuria (PKU) and Chronic Kidney Disease (CKD). Phase 1 findings indicate robust pharmacological activity, affirming the mechanistic effic...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 76.84
Price to Sales (Expected) -
Price to Book 3.39
PEG (TTM) -

Financial Strength Current
Quick Ratio 17.9
Working Capital Ratio 18.43
Leverage Ratio (MRQ) 0.17
Total Debt to Equity 0.09
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.67 $
Revenues (TTM) 0.34 $
Cash Flow (TTM) -
Cash 6.97 $
Book Value 7.68 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -947,447
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.